MMSL 2012, 81(1):9-15 | DOI: 10.31482/mmsl.2012.002

TOPICALLY-USED GENTAMICIN ATTACHED TO NANOFIBRE MDOCTM COMPARED WITH GARAMYCIN SCHWAMM® IN AN ACUTE WOUND INFECTION MODEL. AN EXPERIMENTAL STUDY.Original article

Petr Lochman ORCID...1,2*, Jiří Páral ORCID...1,2, Dušan Šimkovič2, Jaromír Kočí ORCID...3
1 Department of Field Surgery, Faculty of Military Health Sciences, University of Defence, Hradec Králové,Czech Republic
2 Department of Surgery, University Hospital, Hradec Králové, Czech Republic
3 Department of Emergency Medicine, University Hospital, Hradec Králové, Czech Republic

The aim of this study was to examine the effect of topically-used gentamicin attached to a biodegradable carrier, formed by micro-dispersed oxidised cellulose (MDOC) in nanofibre form, in acute wound infection treatment and to compare it with Garamycin Schwamm®. Twelve domestic swines were used in a model of a full-thickness infected dermal wound. The effectiveness of both materials in wound infections caused by Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli was tested. The effectiveness of both gentamicin with MDOC and Garamycin Schwamm® was comparable in Pseudomonas aeruginosa and Escherichia coli infections according to microbiological cultures findings. With Staphylococcus aureus infections there was a higher percent of negative cultures when MDOC with gentamicin was administered, but without statistical significance (p=0.069). When macroscopically assesed, 100 % of infected wounds treated by gentamicin attached to MDOC were without signs of local infection compared to only 16.7 % when Garamycin Schwamm® was used and this was statistically significant (p<0.01). For statistical analysis we used a Fisher's exact test. When combined with a nanofibre MDOC carrier, topically-used gentamicin seems to be rendered more for treatment of full-thickness skin infections. The resulting good haemostatic effect of MDOC was observed.

Keywords: gentamicin; micro-dispersed oxidised cellulose; wound infection; Garamycin Schwamm

Received: November 15, 2011; Revised: February 12, 2012; Published: March 9, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lochman, P., Páral, J., Šimkovič, D., & Kočí, J. (2012). TOPICALLY-USED GENTAMICIN ATTACHED TO NANOFIBRE MDOCTM COMPARED WITH GARAMYCIN SCHWAMM® IN AN ACUTE WOUND INFECTION MODEL. AN EXPERIMENTAL STUDY. MMSL, 81(1), 9-15. doi: 10.31482/mmsl.2012.002
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Smyth, ETM.; McIlvenny, G.; Enstone, JE.; Emmerson, AM.; Humphreys, H.; Fitzpatrick, F.; Davies, E.; Newcombe, RG.; Spencer, RC. and on behalf of the Hospital Infection Society Prevalence Survey Steering Group. Four country healthcare associated infection prevalence survey 2006: overview of the results. J. Hosp. Infect. 2008, 69, 230-248. Go to original source... Go to PubMed...
    2. Diehr, S.; Hamp, A.; Jamieson, B. Do topical antibiotics improve wound healing? J. Fam. Pract. 2007, 56, 140-144.
    3. Kraus, SJ.; Eron, LJ.; Bottenfield, GW.; Drehobl, MA.; Bushnell, WD.; Cupo, MA. Mupirocin cream is as effective as oral cephalexin in the treatment of secondarily infected wounds. J. Fam. Pract. 1998, 47, 429-433.
    4. O'Meara, SM.; Cullum, NA.; Majid, M.; Sheldon, TA. Systematic review of antimicrobial agents used for chronic wounds. Br. J. Surg. 2001, 88, 4-21. Go to original source... Go to PubMed...
    5. Eklund, AM. Prevention of sternal wound infections with locally administered gentamicin. APMIS 2007,115,1022-1024. Go to original source... Go to PubMed...
    6. Friberg, Ö.; Svedjeholm, R.; Källman, J.; Söderquist, B. Incidence, microbiological findings, and clinical presentation of sternal wound infections after cardiac surgery with and without local gentamicin prophylaxis. Eur. J. Clin. Microbiol. Infect. Dis. 2007, 26, 91-97. Go to original source... Go to PubMed...
    7. Eklund, AM.; Valtonen, M.; Werkkala, KA. Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery. J. Hosp. Infect. 2005, 59,108-112. Go to original source... Go to PubMed...
    8. Friberg, Ö.; Jones, I.; Sjöberg, L.; Söderquist, B.; Vikerfors, T.; Källman, J. Antibiotic concentrations in serum and wound fluid after local gentamicin or intravenous dicloxacillin prophylaxis in cardiac surgery. Scand. J. Infect. Dis. 2003, 35, 251-254. Go to original source... Go to PubMed...
    9. Leyh, RG.; Bartels, C.; Sievers, H-H. Adjuvant treatment of deep sternal wound infection with collagenous gentamycin. Ann. Thorac. Surg. 1999, 68, 1648-1651. Go to original source... Go to PubMed...
    10. Friberg, Ö. Local collagen-gentamicin for prevention of sternal wound infections: the LOGIP trial. APMIS 2007, 115, 1016-1021. Go to original source... Go to PubMed...
    11. Schersten, H. Modified prophylaxis for preventing deep sternal wound infection after cardiac surgery. APMIS 2007, 115, 1025-1028. Go to original source... Go to PubMed...
    12. Friberg, Ö.; Svedjeholm, R.; Söderquist, B.; Granfeldt, H.; Vikerfors, T.; Källman J. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann. Thorac. Surg. 2005, 79, 153-161; discussion 161-162. Go to original source... Go to PubMed...
    13. Eveillard, M.; Mertl, P.; Tramier, B.; Eb, F. Effectiveness of gentamicin-impregnated cement in the prevention of deep wound infection after primary total knee arthroplasty. Infect. Control. Hosp. Epidemiol. 2003, 24, 778-780. Go to original source... Go to PubMed...
    14. Musella, M.; Guido, A.; Musella, S. Collagen tampons as aminoglycoside carriers to reduce postoperative infection rate in prosthetic repair of groin hernias. Eur. J. Surg. 2001, 167, 130-132. Go to original source... Go to PubMed...
    15. Buimer, MG.; Ankersmit, MFP.; Wobbes, T.; Klinkenbijl, JHG. Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol. Surg. 2008, 34, 224-227. Go to original source... Go to PubMed...
    16. Holzer, B.; Grüssner, U.; Brückner, B.; Houf, M.; Kiffner, E.; Schildberg, FW.; Vogel, P.; Rosen, HR. and the EMD study group. Efficacy and tolerance of a new gentamicin collagen fleece (Septocoll®) after surgical treatment of a pilonidal sinus. Colorectal. Dis. 2003, 5, 222-227. Go to original source... Go to PubMed...
    17. Gustafsson, U-M.; Graf, W. Randomized clinical trial of local gentamicin-collagen treatment in advancement flap repair for anal fistula. Br. J. Surg. 2006, 93, 1202-1207. Go to original source... Go to PubMed...
    18. Haase, O.; Raue, W.; Böhm, B.; Neuss, H.; Scharfenberg, M.; Schwenk, W. Subcutaneous gentamycin implant to reduce wound infections after loop-ileostomy closure: a randomized double-blind, placebo-controlled trial. Dis. Col. Rectum 2005, 48, 2025-2031. Go to original source... Go to PubMed...
    19. Grüssner, U.; Clemens, M.; Pahlplatz, PV.; Sperling, P.; Witte, J.; Rosen, HR. Improvement of perineal wound healing by local administration of gentamicin-impregnated collagen fleeces after abdominoperineal excision of rectal cancer. Am. J. Surg. 2001, 182, 502-509. Go to original source... Go to PubMed...
    20. Rosen, HR.; Marczell, APOD.; Czerwenka, E.; Stierer, MO.; Spoula, H.; Wasl, H. Local gentamicin application for perineal wound-healing following abdominoperineal rectum excision. Am. J. Surg. 1992, 162, 438-441.
    21. Gomez, GV.; Guerrero, TS.; Lluck, MC.; Delgado, FJ. Effectiveness of collagen-gentamicin implant for treatment of "dirty" abdominal wounds. World J. Surg. 1999, 23, 123-127. Go to original source... Go to PubMed...
    22. Křížová, P.; Mášová, L.; Suttnar, J.; Salaj, P.; Dyr, JE.; Homola, J.; Pecka, M. The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose. J Biomed Mater Res. Part A 2007, 82, 274-280.
    23. Mášová, L.; Ryšavá, J.; Křížová, P.; Suttnar, J.; Salaj, P.; Dyr, JE.; Homola, J.; Dostálek, J.; Myška, K.; Pecka, M. Hemostyptic effect of oxidized cellulose on blood platelets. Sborník lékařský 2003, 104, 231-236. Go to PubMed...
    24. Vashishta, R.; Chhibber, S.; Saxena, M. Heavy metal resistance in clinical isolates of Pseudomonas aeruginosa. Folia Microbiol. (Praha) 1989, 34, 448-452. Go to original source... Go to PubMed...
    25. de Vicente, A.; Aviles, M.; Codina, JC.; et al. Resistance to antibiotics and heavy metals of Pseudomonas aeruginosa isolated from natural waters. J. Appl. Bacteriol. 1990, 68, 625-632. Go to original source... Go to PubMed...
    26. Silver, S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol. Rev. 2003, 27, 341-353. Go to original source... Go to PubMed...

    Return to the content